First Trust Advisors LP Co Diagnostics, Inc. Transaction History

First Trust Advisors LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.04 - $1.64 $1,182 - $1,864	-1,137 Reduced 1.38%	81,176 $90,000
Q1 2023 May 15, 2023	BUY	$1.39 - $3.24 $8,723 - $20,334	6,276 Added 8.25%	82,313 $121,000
Q4 2022 Feb 09, 2023	SELL	$2.32 - $3.68 $29,730 - $47,159	-12,815 Reduced 14.42%	76,037 $191,000
Q3 2022 Nov 14, 2022	BUY	$2.87 - $7.01 $118,183 - $288,664	41,179 Added 86.38%	88,852 $285,000
Q2 2022 Aug 12, 2022	BUY	$3.76 - $6.29 $21,236 - $35,525	5,648 Added 13.44%	47,673 $267,000
Q1 2022 May 13, 2022	SELL	$5.03 - $9.61 $10,200 - $19,489	-2,028 Reduced 4.6%	42,025 $260,000
Q4 2021 Feb 08, 2022	BUY	$8.12 - $10.37 $44,310 - $56,589	5,457 Added 14.14%	44,053 $393,000
Q3 2021 Nov 15, 2021	BUY	$7.48 - $11.38 $288,698 - $439,222	38,596 New	38,596 $376,000

4.3M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $35.8M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.